GCBUX | RLBAX | GCBUX / RLBAX | |
Total Expense Ratio | 1.16 | 1.31 | 89% |
Annual Report Gross Expense Ratio | 1.16 | 1.31 | 89% |
Fund Existence | 5 years | 23 years | - |
Gain YTD | 5.303 | 8.565 | 62% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 250 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 383M | 254B | 0% |
Annual Yield % from dividends | 0.74 | 1.18 | 63% |
Returns for 1 year | 0.89 | 9.42 | 9% |
Returns for 3 years | 16.34 | 32.14 | 51% |
Returns for 5 years | N/A | 35.28 | - |
Returns for 10 years | N/A | 58.06 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BNDI | 46.83 | 0.11 | +0.23% |
NEOS Enhanced Income Aggregate Bond ETF | |||
BBAGF | 42.50 | N/A | N/A |
BB Biotech AG | |||
LOCT | 23.92 | N/A | N/A |
Innovator Premium Income 15 Buf ETF -Oct | |||
XOP | 128.02 | -0.77 | -0.60% |
SPDR® S&P Oil & Gas Explor & Prodtn ETF | |||
USOI | 52.38 | -0.63 | -1.18% |
UBS ETRACS Crude Oil Shares Cov Cll ETN |